Vontobel Holding
RIGL icon

Vontobel Holding’s Rigel Pharmaceuticals RIGL Stock Holding History

Vontobel Holding’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,000
Closed -$44.4K – 1139
2024
Q1 		$44.4K Hold
3,000
– – ﹤0.01% 1059
2023
Q4 		$43.5K Hold
3,000
– – ﹤0.01% 1072
2023
Q3 		$32.4K Hold
3,000
– – ﹤0.01% 1050
2023
Q2 		$38.7K Buy
+3,000
New +$40.6K ﹤0.01% 1083

Other funds holding RIGL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Vontobel Holding's RIGL Position: Q2 2024 in Review

Vontobel Holding sold out of Rigel Pharmaceuticals (RIGL) in Q2 2024, closing a stake of 3,000 shares — an estimated $44.4K sold.

Vontobel Holding first reported a position in RIGL in Q2 2023 and held it in 4 quarters. The position peaked at $44.4K in Q1 2024. 91 funds tracked by Wall St. Rank hold RIGL as of Q2 2024.

  • Vontobel Holding reported no remaining Rigel Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Vontobel Holding sold 3,000 Rigel Pharmaceuticals shares in Q2 2024, an estimated $44.4K.
  • Vontobel Holding first reported a position in Rigel Pharmaceuticals in Q2 2023 and held it in 4 quarters.
  • Vontobel Holding's Rigel Pharmaceuticals position peaked at $44.4K in Q1 2024.
  • 91 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2024.

Based on Vontobel Holding's 13F filing for Q2 2024, filed 13 Aug 2024.